GalantamineHydrobromideCAS# 69353-21-5 |
2D Structure
Quality Control & MSDS
Package In Stock
Number of papers citing our products
Cas No. | 69353-21-5 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C17H22BrNO3 | M.Wt | 368.27 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
GalantamineHydrobromide Dilution Calculator
GalantamineHydrobromide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7154 mL | 13.577 mL | 27.154 mL | 54.308 mL | 67.885 mL |
5 mM | 0.5431 mL | 2.7154 mL | 5.4308 mL | 10.8616 mL | 13.577 mL |
10 mM | 0.2715 mL | 1.3577 mL | 2.7154 mL | 5.4308 mL | 6.7885 mL |
50 mM | 0.0543 mL | 0.2715 mL | 0.5431 mL | 1.0862 mL | 1.3577 mL |
100 mM | 0.0272 mL | 0.1358 mL | 0.2715 mL | 0.5431 mL | 0.6788 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Delphinidin-3-Rutinoside Delphinidin-3-Rutinosidechloride
Catalog No.:BCX0880
CAS No.:58285-26-0
- Delphinidin-3-O-arabinoside
Catalog No.:BCX0879
CAS No.:28500-01-8
- Cyanidin3-O-2G-glucosylrutinoside
Catalog No.:BCX0878
CAS No.:755695-57-9
- Cyanidin-3-Rutinosidechloride Cyanidin-3-Rutinoside
Catalog No.:BCX0877
CAS No.:28338-59-2
- Ilexgenin B
Catalog No.:BCX0876
CAS No.:109008-39-1
- Quercitin-3′-O- glucofuranoside
Catalog No.:BCX0875
CAS No.:21637-25-2
- Demethoxydeacetoxypseudolaric acid B
Catalog No.:BCX0874
CAS No.:500736-17-4
- Breviscapine
Catalog No.:BCX0873
CAS No.:116122-36-2
- Celosin K
Catalog No.:BCX0872
CAS No.:1950579-53-9
- N-acetyldopamine dimmers A
Catalog No.:BCX0871
CAS No.:1519015-73-6
- Lugrandoside
Catalog No.:BCX0870
CAS No.:117457-37-1
- Acetyl Dopamine DimerIII
Catalog No.:BCX0869
CAS No.:916888-49-8
- (+)-Medicarpin
Catalog No.:BCX0882
CAS No.:33983-40-3
- Benzoylalbiflorin
Catalog No.:BCX0883
CAS No.:184103-78-4
- Allosecurinin
Catalog No.:BCX0884
CAS No.:884-68-4
- Lucenin-1 Luteolin-6-C-β-D-xylopyranoside-8-C-β-D-glucopyranosyl
Catalog No.:BCX0885
CAS No.:35927-39-0
- Lucenin-3 Luteolin-6-C-β-D-glucopyranosyl-8-C-β-D-xylopyranoside
Catalog No.:BCX0886
CAS No.:12656-83-6
- IsovitexinApigenin6-C-glucoside
Catalog No.:BCX0887
CAS No.:29702-25-8
- Delphinidin3-O-(6''-coumaroylglucoside)
Catalog No.:BCX0888
CAS No.:136031-08-8
- peonidin-3-O-(6''-coumaroyl)glucoside-5-O-glucoside
Catalog No.:BCX0889
CAS No.:205505-30-2
- Peonidin3-O-(6-O-p-coumaroyl)glucoside
Catalog No.:BCX0890
CAS No.:305833-55-0
- petunidin-3-O-(6"-O-p-coumaroyl)glucoside-5-O-diglucoside
Catalog No.:BCX0891
CAS No.:1063818-55-2
- Malvidin3-O-(6''-coumaroyl)glucoside
Catalog No.:BCX0892
CAS No.:158189-28-7
- Malvidin-3-O-(6''-O-coumaroyl)glucoside-5-O-glucoside
Catalog No.:BCX0893
CAS No.:144940-56-7
Study on novel galantaminehydrobromide sustained-release capsules and itsin vitro releasing property.[Pubmed:25262508]
Pak J Pharm Sci. 2014 Sep;27(5 Suppl):1621-6.
In present study, we prepared a novel galantamine hydro bromide sustained-release capsules with the new manufacturing technology, extrusion-spheronization method, and the optimized preparative formulation. A simple, rapid and accurate high performance liquid chromatography method (HPLC) was developed and validated for the quantification and release evaluation of galantamine hydro bromide. Experimental results showed that the method was specific, sensitive and reliable, could be effectively applied to the in vitro release study of galantamine hydro bromide sustained-release capsules. Our resulting samples had superior properties, worked better as sustained-release carriers and lasted longer hours to release drugs compared with the marketed control, Razadyne ER. The in vitro releasing characteristics of different batches of preparations are quite similar with each other, the total release proportions of galantamine hydro bromide from sustained-release capsules reached higher than 90 % within 12 h. The testing sustained-release preparation may be a promising new product for curing the related diseases.